Form 4 for LLY Lilly (Eli)
Accepted 2025-03-03 00:00:00 ET · period of report 2025-03-01 · accession 0000059478-25-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-03-01 | LLY | Dozier Eric | EVP, CHRO | M - OptEx | $0.00 | +2,403 | 10.9K | +28% | $0 |
| D | 2025-03-03 | 2025-03-01 | LLY | Dozier Eric | EVP, CHRO | F - Tax | $920.63 | -1,066 | 9,839 | -10% | -$981.6K |
| D | 2025-03-03 | 2025-03-01 | LLY | Dozier Eric | EVP, CHRO | M - OptEx | $0.00 | -2,403 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | M | A | 2,403 | $0.00 | 10,905.12 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-01 | F | D | 1,066.21 | $920.63 | 9,838.91 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-03-01 | M | D | 2,403 | $0.00 | 0 | D | — · 2025-03-01 to 2025-03-01 | 2,403 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |